Review ArticleWhat's in the Neuromuscular Junction Literature?Lacomis, David MDAuthor Information Departments of Neurology and Pathology (Neuropathology), University of Pittsburgh School of Medicine, Pittsburgh, PA. Reprints: David Lacomis, MD, Departments of Neurology and Pathology (Neuropathology), University of Pittsburgh School of Medicine, UPMC-Presbyterian, Room F872, 200 Lothrop St. Pittsburgh, PA 15213 (e-mail: email@example.com). The author reports no conflicts of interest. Journal of Clinical Neuromuscular Disease: June 2020 - Volume 21 - Issue 4 - p 195-204 doi: 10.1097/CND.0000000000000285 Buy Metrics Abstract Four retrospective studies from the United States, Europe, and Asia address outcomes in juvenile myasthenia gravis. Common features include earlier onset with ocular myasthenia gravis (MG) and generally good outcomes overall. Patients who were seronegative, had equivocal acetylcholine receptor (AChR) antibodies, or had only clustered AChR antibodies had better outcomes. An article highlighting the utility of median nerve slow-repetitive stimulation is reviewed and another showing the high sensitivity of repetitive nerve stimulation in myasthenic crisis is covered. Two articles address the thymus and thymectomy in non-AChR antibody-positive autoimmune MG. Longer term data on eculizumab as well as studies of cyclophosphamide, rituximab, and tacrolimus are summarized. Other topics include the possible role of statins in MG and central nervous system autoimmune comorbidities. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.